Australia markets closed

Silence Therapeutics plc (SLNCF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
7.10-0.50 (-6.58%)
At close: 01:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.06B
Enterprise value 868.80M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)26.43
Price/book (mrq)6.72
Enterprise value/revenue 25.72
Enterprise value/EBITDA -5.61

Trading information

Stock price history

Beta (5Y monthly) 1.33
52-week change 3475.76%
S&P500 52-week change 324.52%
52-week high 310.90
52-week low 30.60
50-day moving average 37.52
200-day moving average 33.41

Share statistics

Avg vol (3-month) 3265
Avg vol (10-day) 3120
Shares outstanding 5139.98M
Implied shares outstanding 6139.51M
Float 878.19M
% held by insiders 129.54%
% held by institutions 133.85%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -132.31%
Operating margin (ttm)-33.50%

Management effectiveness

Return on assets (ttm)-18.02%
Return on equity (ttm)-49.74%

Income statement

Revenue (ttm)26.41M
Revenue per share (ttm)0.68
Quarterly revenue growth (yoy)9.10%
Gross profit (ttm)N/A
EBITDA -41.29M
Net income avi to common (ttm)-34.94M
Diluted EPS (ttm)-0.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)152.75M
Total cash per share (mrq)1.09
Total debt (mrq)277k
Total debt/equity (mrq)0.22%
Current ratio (mrq)12.82
Book value per share (mrq)2.66

Cash flow statement

Operating cash flow (ttm)-39.19M
Levered free cash flow (ttm)-25.68M